Literature DB >> 22136407

Analgesic concentrations of oxycodone--a prospective clinical PK/PD study in patients with laparoscopic cholecystectomy.

Merja Kokki1, Susanna Broms, Matti Eskelinen, Ilpo Rasanen, Ilkka Ojanperä, Hannu Kokki.   

Abstract

The analgesic concentrations of oxycodone in acute post-operative pain management have not been established. Here, we have evaluated the minimum effective concentration (MEC) and the minimum effective analgesic concentration (MEAC) of oxycodone in pain after laparoscopic cholecystectomy (LCC) in 23 adult patients. The patients were provided with 0.1 mg/kg of oxycodone i.v. 10-15 min. before the end of surgery. After surgery, when the wound pain at rest was ≥3/10 and/or ≥5/10 during wound compression, a first blood sample was obtained (MEC). A second blood sample was obtained after titration with 2 mg i.v. of oxycodone to wound pain <3/10 at rest and <5/10 during wound compression (MEAC). A third blood sample was obtained at the recurrence of the wound pain (the second MEC), and the final blood sample when pain relief was obtained a second time (the second MEAC). At the first onset of pain (MEC), mean P-oxycodone was 21 ng/mL (95% CI 13-29 ng/mL). At the first pain relief (MEAC), P-oxycodone was 55 ng/mL (19-91 ng/mL). The second MEC was 34 ng/mL (11-57 ng/mL), and the second MEAC was 47 ng/mL (14-80 ng/mL). In conclusion, the estimated MEC, 20-35 ng/mL, and MEAC, 45-50 ng/mL, values of P-oxycodone in patients after LLC were significantly higher than those proposed previously. Early pain after LCC appeared to be a feasible method to estimate the analgesic efficacy of oxycodone in acute pain management.
© 2011 The Authors. Basic & Clinical Pharmacology & Toxicology © 2011 Nordic Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22136407     DOI: 10.1111/j.1742-7843.2011.00839.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  18 in total

1.  Analgesic efficacy and pharmacokinetics of epidural oxycodone in pain management after gynaecological laparoscopy-A randomised, double blind, active control, double-dummy clinical comparison with intravenous administration.

Authors:  Panu Piirainen; Hannu Kokki; Brian Anderson; Jacqueline Hannam; Heidi Hautajärvi; Veli-Pekka Ranta; Merja Kokki
Journal:  Br J Clin Pharmacol       Date:  2019-06-20       Impact factor: 4.335

Review 2.  Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone.

Authors:  Mari Kinnunen; Panu Piirainen; Hannu Kokki; Pauliina Lammi; Merja Kokki
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

3.  The analgesic efficacy and pharmacokinetics of epidural oxycodone after gynaecological laparotomy: a randomized, double-blind, double-dummy comparison with intravenous administration.

Authors:  Panu Piirainen; Hannu Kokki; Heidi Hautajärvi; Veli-Pekka Ranta; Merja Kokki
Journal:  Br J Clin Pharmacol       Date:  2018-06-21       Impact factor: 4.335

4.  Population pharmacokinetics and analgesic potency of oxycodone.

Authors:  Byung-Moon Choi; Yong-Hun Lee; Sang-Mee An; Soo-Han Lee; Eun-Kyung Lee; Gyu-Jeong Noh
Journal:  Br J Clin Pharmacol       Date:  2016-09-29       Impact factor: 4.335

5.  Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical Trials.

Authors:  Pyry Välitalo; Merja Kokki; Veli-Pekka Ranta; Klaus T Olkkola; Andrew C Hooker; Hannu Kokki
Journal:  Pharm Res       Date:  2017-02-15       Impact factor: 4.200

Review 6.  Pharmacokinetic Pharmacodynamic Modelling Contributions to Improve Paediatric Anaesthesia Practice.

Authors:  James D Morse; Luis Ignacio Cortinez; Brian J Anderson
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

Review 7.  Laparoscopic surgery: a narrative review of pharmacotherapy in pain management.

Authors:  Sari Sjövall; Merja Kokki; Hannu Kokki
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

8.  Oxycodone vs. fentanyl patient-controlled analgesia after laparoscopic cholecystectomy.

Authors:  Boo-Young Hwang; Jae-Young Kwon; Eunsoo Kim; Do-Won Lee; Tae-Kyun Kim; Hae-Kyu Kim
Journal:  Int J Med Sci       Date:  2014-04-30       Impact factor: 3.738

9.  Intranasal Fentanyl for Intervention-Associated Breakthrough Pain After Cardiac Surgery.

Authors:  Antti Valtola; Maisa Laakso; Henriikka Hakomäki; Brian J Anderson; Hannu Kokki; Veli-Pekka Ranta; Valtteri Rinne; Merja Kokki
Journal:  Clin Pharmacokinet       Date:  2021-03-09       Impact factor: 6.447

10.  A Dose-Finding Study of Dexketoprofen in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial on Effects on the Analgesic Concentration of Oxycodone.

Authors:  Annika Piirainen; Hannu Kokki; Satu Immonen; Matti Eskelinen; Merja R Häkkinen; Heidi Hautajärvi; Merja Kokki
Journal:  Drugs R D       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.